Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 14 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

Phase 2
1(100.0%)
1Total
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials
NCT07401173Recruiting

DeepComp for Prediction of Gastric Cancer Postoperative Complications (DeepComp-Prospective)

Role: lead

NCT07454967Completed

Development of a Multimodal AI System for GIST Management

Role: lead

NCT07401199Not Yet Recruiting

Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)

Role: lead

NCT07124754Recruiting

Multimodal Deep Learning for Lymph Node Metastasis Prediction and Physician Performance Assessment in T1 Gastric Cancer

Role: lead

NCT06478368Completed

Prediction of Occult Peritoneal Metastasis of Locally Advanced Gastric Cancer Using Multimodal Data Based on Artificial Intelligence Combined With Intraoperative Dynamic Video

Role: lead

NCT06979817Completed

Machine Learning Model Guided by TLS Predicts Survival and Immune Features in Gastric Cancer

Role: lead

NCT06957678Enrolling By Invitation

AI-Based Prediction of Lymph Node Metastasis in Gastric Cancer Using Preoperative Multimodal Data

Role: lead

NCT06947096Enrolling By Invitation

Radiomics-Based AI Model for Predicting Para-Aortic Lymph Node Metastasis in Gastric Cancer Patients

Role: lead

NCT06858644Not Yet Recruiting

Development of a Predictive Model for Gastric Cancer Peritoneal Metastasis and Cachexia Using BUB1 and Radiopathomics Data With Deep Learning

Role: lead

NCT06759467Completed

Diagnosis of Peritoneal Exfoliative Cytology-positive Gastric Cancer Based on Artificial Intelligence-driven Virtual Biopsy Technology

Role: lead

NCT06690268Completed

Multimodal Model Predicts Recurrence

Role: lead

NCT06506825Recruiting

Construction and Application of Database of Hebei Provincial Gastric Cancer Collaborative Network Driven by Artificial Intelligence Technology

Role: lead

NCT06478394Recruiting

Machine Learning-driven Noninvasive Screening of Transcriptomics Liquid Biopsies for Early Diagnosis of Occult Peritoneal Metastases in Locally Advanced Gastric Cancer

Role: lead

NCT02555358Phase 2Completed

Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study

Role: lead

All 14 trials loaded